Make Sheffield the start of something special. When you study here you get one of the best student experiences in the UK. At Sheffield, you’ll join a supportive community of scholars who share your ...
British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.
GSK declared a third-quarter dividend of 15.00 pence per share, unchanged from the second quarter, but up 7.1% from 14.00p per share last year. It continues to expect a total dividend of 60.00p per ...
Following the resolution of the Zantac heartburn medicine legal overhang, analysts are now fretting over the strength of its vaccine sales. Traumatised investors require a long period of peace and ...
"These defendants orchestrated an elaborate kickback scheme that cost the state nearly $10 million. This decision, imposing $39 million in treble damages as well as civil penalties, sends a clear ...
The shares crashed 9% on 3 June after a Delaware judge gave the green light to 70,000 Zantac lawsuits. Then Morgan Stanley terrified investors by claiming GSK could take a staggering $30bn hit. Having ...
How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...
If you or a loved one took Zantac (ranitidine) and later developed health complications, particularly cancer, you may be entitled to legal compensation through a Zantac lawsuit. Due to increasing ...